Tau oligomers in cerebrospinal fluid in Alzheimer's disease

OBJECTIVE: With an increasing incidence of Alzheimer's disease (AD) and neurodegenerative tauopathies, there is an urgent need to develop reliable biomarkers for the diagnosis and monitoring of the disease, such as the recently discovered toxic tau oligomers. Here, we aimed to demonstrate the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Urmi, Portelius, Erik, Hansson, Oskar, Farmer, Kathleen, Castillo‐Carranza, Diana, Woltjer, Randall, Zetterberg, Henrik, Galasko, Douglas, Blennow, Kaj, Kayed, Rakez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376754/
https://www.ncbi.nlm.nih.gov/pubmed/28382304
http://dx.doi.org/10.1002/acn3.382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376754/
https://www.ncbi.nlm.nih.gov/pubmed/28382304
http://dx.doi.org/10.1002/acn3.382

Ejemplares similares